N4 Pharma PLC - Asset Resilience Ratio

Latest as of December 1990: 0.13%

N4 Pharma PLC (N4P) has an Asset Resilience Ratio of 0.13% as of December 1990. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check N4P PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

GBX20.00K

≈ $2.43 USD Cash + Short-term Investments

Total Assets

GBX15.85 Million

≈ $1.93K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1990–2016)

This chart shows how N4 Pharma PLC's Asset Resilience Ratio has changed over time. See N4P equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down N4 Pharma PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see N4P company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX20.00K	0.13%
Total Liquid Assets	GBX20.00K	0.13%

Asset Resilience Insights

Limited Liquidity: N4 Pharma PLC maintains only 0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

N4 Pharma PLC Industry Peers by Asset Resilience Ratio

Compare N4 Pharma PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for N4 Pharma PLC (1990–2016)

The table below shows the annual Asset Resilience Ratio data for N4 Pharma PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	20.75%	GBX232.00K ≈ $28.23	GBX1.12 Million ≈ $136.03	+20.63pp
1990-12-31	0.13%	GBX20.00K ≈ $2.43	GBX15.85 Million ≈ $1.93K	--

pp = percentage points

About N4 Pharma PLC

LSE:N4P UK Drug Manufacturers - Specialty & Generic

Market Cap

$48.10K

GBX395.33 Million GBX

Market Cap Rank

#31424 Global

#1208 in UK

Share Price

GBX0.48

Change (1 day)

+0.00%

52-Week Range

GBX0.38 - GBX0.73

All Time High

GBX32.90